Literature DB >> 12223261

Polydipsia and schizophrenia in a psychiatric hospital: a replication study.

Jose de Leon1, Joseph Tracy, Eileen McCann, Amy McGrory.   

Abstract

A prior study in a US state hospital suggested that schizophrenia, smoking and long hospitalization were associated with polydipsia. This study, in another US hospital, attempts to (1) replicate that schizophrenia and smoking are associated with polydipsia, and (2) rule out that this relationship is partly explained by alcohol and drug use. Both studies have similar methodologies. The second sample included 588 inpatients. Models of variables associated with polydipsia were developed using logistic regression. In the second study, after correcting for other factors, the association between polydipsia and schizophrenia showed a borderline significance, while polydipsia and smoking displayed a significant association. Neither organic brain lesions, nor alcohol or drug use, were associated with polydipsia. An analysis combining both samples showed that: (1) schizophrenia, long hospitalization, smoking and heavy smoking were significantly associated with polydipsia, and (2) male gender and Caucasian race (but not smoking) increased the risk of developing water intoxication in polydipsic patients. These two studies in severely mentally ill patients suggest that the association of polydipsia with schizophrenia, smoking and chronicity is consistent and independent from the definition of polydipsia (by staff, a biological method or the combination of both). Psychiatric medications do not appear to explain most cases of polydipsia in these patients.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12223261     DOI: 10.1016/s0920-9964(01)00292-4

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  15 in total

1.  Do psychoactive drugs have a therapeutic role in compulsivity? Studies on schedule-induced polydipsia.

Authors:  Elena Martín-González; Ángeles Prados-Pardo; Santiago Mora; Pilar Flores; Margarita Moreno
Journal:  Psychopharmacology (Berl)       Date:  2018-01-08       Impact factor: 4.530

2.  Activation of serotonin 5-HT2A receptors inhibits high compulsive drinking on schedule-induced polydipsia.

Authors:  Silvia Victoria Navarro; Valeria Gutiérrez-Ferre; Pilar Flores; Margarita Moreno
Journal:  Psychopharmacology (Berl)       Date:  2014-08-26       Impact factor: 4.530

3.  Early nicotine withdrawal and transdermal nicotine effects on neurocognitive performance in schizophrenia.

Authors:  Christopher G AhnAllen; Paul G Nestor; Martha E Shenton; Robert W McCarley; Margaret A Niznikiewicz
Journal:  Schizophr Res       Date:  2007-09-19       Impact factor: 4.939

Review 4.  Postmortem diagnosis of hyponatremia: case report and literature review.

Authors:  Jessica Vanhaebost; Cristian Palmiere; Maria Pia Scarpelli; Fabiola Bou Abdallah; Arnaud Capron; Gregory Schmit
Journal:  Int J Legal Med       Date:  2017-05-13       Impact factor: 2.686

5.  Antipsychotic use is a risk factor for hyponatremia in patients with schizophrenia: a 15-year follow-up study.

Authors:  Hang-Ju Yang; Wan-Ju Cheng
Journal:  Psychopharmacology (Berl)       Date:  2017-01-11       Impact factor: 4.530

Review 6.  Primary polydipsia: Update.

Authors:  Leeda Ahmadi; Morris B Goldman
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2020-10-14       Impact factor: 4.690

Review 7.  Schedule-induced polydipsia as a model of compulsive behavior: neuropharmacological and neuroendocrine bases.

Authors:  Margarita Moreno; Pilar Flores
Journal:  Psychopharmacology (Berl)       Date:  2011-11-24       Impact factor: 4.530

8.  Poor inhibitory control and neurochemical differences in high compulsive drinker rats selected by schedule-induced polydipsia.

Authors:  Margarita Moreno; Valeria Edith Gutiérrez-Ferre; Luis Ruedas; Leticia Campa; Cristina Suñol; Pilar Flores
Journal:  Psychopharmacology (Berl)       Date:  2011-11-24       Impact factor: 4.530

Review 9.  Antipsychotic-induced hyponatraemia: a systematic review of the published evidence.

Authors:  Didier Meulendijks; Cyndie K Mannesse; Paul A F Jansen; Rob J van Marum; Toine C G Egberts
Journal:  Drug Saf       Date:  2010-02-01       Impact factor: 5.606

10.  EFA supplementation in children with inattention, hyperactivity, and other disruptive behaviors.

Authors:  Laura Stevens; Wen Zhang; Louise Peck; Thomas Kuczek; Nels Grevstad; Anne Mahon; Sydney S Zentall; L Eugene Arnold; John R Burgess
Journal:  Lipids       Date:  2003-10       Impact factor: 1.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.